The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Myeloid-derived Suppressor Cells Are Necessary for Development of Pulmonary Hypertension
Open accessAbstract
Pulmonary hypertension (PH) complicates the care of patients with chronic lung disease, such as idiopathic pulmonary fibrosis (IPF), resulting in a significant increase in morbidity and mortality. Disease pathogenesis is orchestrated by unidentified myeloid-derived cells. We used murine models of PH and pulmonary fibrosis to study the role of circulating myeloid cells in disease pathogenesis and prevention. We administered clodronate liposomes to bleomycin-treated wild-type mice to induce pulmonary fibrosis and PH with a resulting increase in circulating bone marrow–derived cells. We discovered that a population of C-X-C motif chemokine receptor (CXCR) 2+ myeloid-derived suppressor cells (MDSCs), granulocytic subset (G-MDSC), is associated with severe PH in mice. Pulmonary pressures worsened despite improvement in bleomycin-induced pulmonary fibrosis. PH was attenuated by CXCR2 inhibition, with antagonist SB 225002, through decreasing G-MDSC recruitment to the lung. Molecular and cellular analysis of clinical patient samples confirmed a role for elevated MDSCs in IPF and IPF with PH. These data show that MDSCs play a key role in PH pathogenesis and that G-MDSC trafficking to the lung, through chemokine receptor CXCR2, increases development of PH in multiple murine models. Furthermore, we demonstrate pathology similar to the preclinical models in IPF with lung and blood samples from patients with PH, suggesting a potential role for CXCR2 inhibitor use in this patient population. These findings are significant, as there are currently no approved disease-specific therapies for patients with PH complicating IPF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“preventing their recruitment via neutralization of CXCR2 normalized the pulmonary pressure (119).”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [119]
Experimental — accuracy not yet measuredIn the citing paper
“Another experiment with bleomycin-induced mice showed that MDSCs triggered vascular remodeling and pulmonary hypertension”
From The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis (2018) · cites this paper as [119]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Bronte, V., Brandau, S., Chen, S.-H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12150 · Cited by 2,751
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Johnson, D. B., Balko, J. M., Compton, M. L., Chalkias, S., Gorham, J., Xu, Y., Hicks, M., Puzanov, I., Alexander, M. R., Bloomer, T. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1609214 · Cited by 2,308
Myeloid-Derived Suppressor Cells
Gabrilovich, D. I. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0297 · Cited by 1,882
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
Du, R., Lu, K. V., Petritsch, C., Liu, P., Ganss, R., Passegué, E., Song, H., VandenBerg, S., Johnson, R. S., Werb, Z., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.034 · Cited by 1,130
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Lettieri, C. J., Nathan, S. D., Barnett, S. D., Ahmad, S., & Shorr, A. F. (2006) · Chest · doi:10.1378/chest.129.3.746 · Cited by 879
Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor
Marigo, I., Bosio, E., Solito, S., Mesa, C., Fernandez, A., Dolcetti, L., Ugel, S., Sonda, N., Bicciato, S., Falisi, E., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.010 · Cited by 850
Rodriguez, P. C., Ernstoff, M. S., Hernandez, C., Atkins, M., Zabaleta, J., Sierra, R., & Ochoa, A. C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1921 · Cited by 773
Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
Highfill, S. L., Cui, Y., Giles, A. J., Smith, J. P., Zhang, H., Morse, E., Kaplan, R. N., & Mackall, C. L. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007974 · Cited by 767
A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002110 · Cited by 634
Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan: A Parallel, Randomized Trial
Raghu, G., Behr, J., Brown, K. K., Egan, J. J., Kawut, S. M., Flaherty, K. R., Martinez, F. J., Nathan, S. D., Wells, A. U., Collard, H. R., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-9-201305070-00003 · Cited by 553
Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis
Gibbons, M. A., MacKinnon, A. C., Ramachandran, P., Dhaliwal, K., Duffin, R., Phythian-Adams, A. T., van Rooijen, N., Haslett, C., Howie, S. E., Simpson, A. J., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201010-1719oc · Cited by 466
Highfill, S. L., Rodriguez, P. C., Zhou, Q., Goetz, C. A., Koehn, B. H., Veenstra, R., Taylor, P. A., Panoskaltsis-Mortari, A., Serody, J. S., Munn, D. H., et al. (2010) · Blood · doi:10.1182/blood-2010-06-287839 · Cited by 465
Frid, M. G., Brunetti, J. A., Burke, D. L., Carpenter, T. C., Davie, N. J., Reeves, J. T., Roedersheimer, M. T., van Rooijen, N., & Stenmark, K. R. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050599 · Cited by 449
King, I. L., Dickendesher, T. L., & Segal, B. M. (2009) · Blood · doi:10.1182/blood-2008-07-168575 · Cited by 444
ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis.
Condamine, T., Kumar, V., Ramachandran, I. R., Youn, J.-I., Celis, E., Finnberg, N., El-Deiry, W. S., Winograd, R., Vonderheide, R. H., English, N. R., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74056 · Cited by 365
Endoplasmic reticulum stress enhances fibrotic remodeling in the lungs
Lawson, W. E., Cheng, D.-S., Degryse, A. L., Tanjore, H., Polosukhin, V. V., Xu, X. C., Newcomb, D. C., Jones, B. R., Roldan, J., Lane, K. B., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107559108 · Cited by 363
TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P
Murray, L. A., Chen, Q., Kramer, M. S., Hesson, D. P., Argentieri, R. L., Peng, X., Gulati, M., Homer, R. J., Russell, T., van Rooijen, N., et al. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.10.013 · Cited by 362
Self-citationThe effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study.
Meyrick, B. O., & REID, L. M. (1978) · PubMed · Cited by 316
Regulatory T Cells Limit Vascular Endothelial Injury and Prevent Pulmonary Hypertension
Tamosiuniene, R., Tian, W., Dhillon, G., Wang, L., Sung, Y. K., Gera, L., Patterson, A. J., Agrawal, R., Rabinovitch, M., Ambler, K., et al. (2011) · Circulation Research · doi:10.1161/circresaha.110.236927 · Cited by 306
Vergadi, E., Chang, M. S., Lee, C., Liang, O. D., Liu, X., Fernandez-Gonzalez, A., Mitsialis, S. A., & Kourembanas, S. (2011) · Circulation · doi:10.1161/circulationaha.110.978627 · Cited by 267
Blocking Macrophage Leukotriene B 4 Prevents Endothelial Injury and Reverses Pulmonary Hypertension
Tian, W., Jiang, X., Tamosiuniene, R., Sung, Y. K., Qian, J., Dhillon, G., Gera, L., Farkas, L., Rabinovitch, M., Zamanian, R. T., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006674 · Cited by 263
CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease
Rennard, S. I., Dale, D. C., Donohue, J. F., Kanniess, F., Magnussen, H., Sutherland, E. R., Watz, H., Lu, S., Stryszak, P., Rosenberg, E., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201405-0992oc · Cited by 261
Carré, P. C., Mortenson, R. L., King, T. E., Noble, P. W., Sable, C. L., & Riches, D. W. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115501 · Cited by 253
Pulmonary arterial remodeling induced by a Th2 immune response
Daley, E., Emson, C., Guignabert, C., de Waal Malefyt, R., Louten, J., Kurup, V. P., Hogaboam, C., Taraseviciene-Stewart, L., Voelkel, N. F., Rabinovitch, M., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071008 · Cited by 253
Identification of Myeloid Cell Subsets in Murine Lungs Using Flow Cytometry
Zaynagetdinov, R., Sherrill, T. P., Kendall, P. L., Segal, B. H., Weller, K. P., Tighe, R. M., & Blackwell, T. S. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0366ma · Cited by 251
Hong, K.-H., Lee, Y. J., Lee, E., Park, S. O., Han, C., Beppu, H., Li, E., Raizada, M. K., Bloch, K. D., & Oh, S. P. (2008) · Circulation · doi:10.1161/circulationaha.107.736801 · Cited by 248
Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension: Connecting the Dots
Nathan, S. D., Noble, P. W., & Tuder, R. M. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200608-1153cc · Cited by 227
Herz, J., Sabellek, P., Lane, T. E., Gunzer, M., Hermann, D. M., & Doeppner, T. R. (2015) · Stroke · doi:10.1161/strokeaha.115.010620 · Cited by 215
Burden of illness in idiopathic pulmonary fibrosis
Collard, H. R., Ward, A. J., Lanes, S., Cortney Hayflinger, D., Rosenberg, D. M., & Hunsche, E. (2012) · Journal of Medical Economics · doi:10.3111/13696998.2012.680553 · Cited by 208
Baran, C. P., Opalek, J. M., McMaken, S., Newland, C. A., O'Brien, J. M., Hunter, M. G., Bringardner, B. D., Monick, M. M., Brigstock, D. R., Stromberg, P. C., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200609-1279oc · Cited by 196
A Central Role for CD68(+) Macrophages in Hepatopulmonary Syndrome: Reversal by Macrophage Depletion
Thenappan, T., Goel, A., Marsboom, G., Fang, Y.-H., Toth, P. T., Zhang, H. J., Kajimoto, H., Hong, Z., Paul, J., Wietholt, C., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201008-1303oc · Cited by 190
Sharma, S. K., Chintala, N. K., Vadrevu, S. K., Patel, J., Karbowniczek, M., & Markiewski, M. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403215 · Cited by 184
Evidence for Right Ventricular Lipotoxicity in Heritable Pulmonary Arterial Hypertension
Hemnes, A. R., Brittain, E. L., Trammell, A. W., Fessel, J. P., Austin, E. D., Penner, N., Maynard, K. B., Gleaves, L., Talati, M., Absi, T., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201306-1086oc · Cited by 178
Lawson, W. E., Polosukhin, V. V., Stathopoulos, G. T., Zoia, O., Han, W., Lane, K. B., Li, B., Donnelly, E. F., Holburn, G. E., Lewis, K. G., et al. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61214-x · Cited by 174
Role of the Chemokine Receptor CXCR2 in Bleomycin-Induced Pulmonary Inflammation and Fibrosis
Russo, R. C., Guabiraba, R., Garcia, C. C., Barcelos, L. S., Roffê, E., Souza, A. L. S., Amaral, F. A., Cisalpino, D., Cassali, G. D., Doni, A., et al. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0364oc · Cited by 139
Myeloid-Derived Suppressor Cells in Bacterial Infections
Ost, M., Singh, A., Peschel, A., Mehling, R., Rieber, N. P., & Hartl, D. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00037 · Cited by 139
Mice expressing BMPR2R899X transgene in smooth muscle develop pulmonary vascular lesions
West, J. D., Harral, J. W., Lane, K. B., Deng, Y., Ickes, B. R., Crona, D. J., Albu, S., Stewart, D. J., & Fagan, K. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90255.2008 · Cited by 137
Draghiciu, O., Nijman, H. W., Hoogeboom, B. N., Meijerhof, T., & Daemen, T. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.989764 · Cited by 135
Endothelin-2 is a macrophage chemoattractant: implications for macrophage distribution in tumors
Grimshaw, M. J., Wilson, J. L., & Balkwill, F. R. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200209)32:9<2393::aid-immu2393>3.0.co;2-4 · Cited by 135
Koehn, B. H., Apostolova, P., Haverkamp, J. M., Miller, J. S., McCullar, V., Tolar, J., Munn, D. H., Murphy, W. J., Brickey, W. J., Serody, J. S., et al. (2015) · Blood · doi:10.1182/blood-2015-03-634691 · Cited by 128
Collard, H. R., Chen, S., Yeh, W., Li, Q., Lee, Y.-C., Wang, A., & Raghu, G. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201412-553oc · Cited by 125
Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension
Amsellem, V., Abid, S., Poupel, L., Parpaleix, A., Rodero, M. P., Gary‐Bobo, G., Latiri, M., Dubois‐Randé, J., Lipskaia, L., Combadière, C., et al. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0201oc · Cited by 124
Bone morphogenetic protein receptor II regulates pulmonary artery endothelial cell barrier function
Burton, V. J., Ciuclan, L. I., Holmes, A. M., Rodman, D. M., Walker, C., & Budd, D. C. (2010) · Blood · doi:10.1182/blood-2010-05-285973 · Cited by 123
Bian, Z., Guo, Y.-L., Ha, B., Zen, K., & Liu, Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101736 · Cited by 111
T-Helper 17 Cell Polarization in Pulmonary Arterial Hypertension
Hautefort, A., Girerd, B., Montani, D., Cohen‐Kaminsky, S., Price, L. C., Lambrecht, B. N., Humbert, M. J. C., & Perros, F. (2014) · CHEST Journal · doi:10.1378/chest.14-1678 · Cited by 104
Degryse, A. L., Tanjore, H., Xu, X. C., Polosukhin, V. V., Jones, B. R., Boomershine, C. S., Ortiz, C., Sherrill, T. P., McMahon, F. B., Gleaves, L. A., et al. (2011) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00397.2010 · Cited by 101
β-Catenin in the Alveolar Epithelium Protects from Lung Fibrosis after Intratracheal Bleomycin
Tanjore, H., Degryse, A. L., Crossno, P. F., Xu, X. C., McConaha, M. E., Jones, B. R., Polosukhin, V. V., Bryant, A. J., Cheng, D., Newcomb, D. C., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201205-0972oc · Cited by 100
Self-citationKarmouty‐Quintana, H., Zhong, H., Acero, L. F., Weng, T., Melicoff, E., West, J. D., Hemnes, A. R., Grenz, A., Eltzschig, H. K., Blackwell, T. S., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-200907 · Cited by 94
Huertas, A., Phan, C., Bordenave, J., Tu, L., Thuillet, R., Hiress, M. L., Avouac, J., Tamura, Y., Allanore, Y., Jovan, R., et al. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.01.004 · Cited by 93
Endothelial HIF signaling regulates pulmonary fibrosis-associated pulmonary hypertension
Bryant, A. J., Carrick, R. P., McConaha, M. E., Jones, B. R., Shay, S. D., Moore, C. S., Blackwell, T. R., Gladson, S., Penner, N. L., Burman, A., et al. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00258.2015 · Cited by 83
Self-citationLin, S., Wang, J., Wang, L., Wen, J., Guo, Y., Qiao, W., Zhou, J., Xu, G., & Zhi, F. (2017) · Europe PMC (PubMed Central) · Cited by 82
Hoh, B. L., Hosaka, K., Downes, D. P., Nowicki, K. W., Fernandez, C. E., Batich, C. D., & Scott, E. W. (2011) · Circulation · doi:10.1161/circulationaha.111.036061 · Cited by 77
Self-citationFernandez, I. E., Greiffo, F. R., Frankenberger, M., Bandres, J., Heinzelmann, K., Neurohr, C., Hatz, R., Hartl, D., Behr, J., & Eickelberg, O. (2016) · European Respiratory Journal · doi:10.1183/13993003.01826-2015 · Cited by 75
Gr1intCD11b+ Myeloid-Derived Suppressor Cells in Mycobacterium tuberculosis Infection
Obregón-Henao, A., Henao-Tamayo, M., Orme, I. M., & Ordway, D. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080669 · Cited by 74
Perros, F., Cohen‐Kaminsky, S., Gambaryan, N., Girerd, B., Raymond, N., Klingel-Schmitt, I., Huertas, A., Mercier, O. M., Fadel, É., Simonneau, G., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201208-1364oc · Cited by 71
Bone Marrow–derived Cells Contribute to the Pathogenesis of Pulmonary Arterial Hypertension
Yan, L., Chen, X., Talati, M. H., Nunley, B., Gladson, S., Blackwell, T., Cogan, J. D., Austin, E. D., Wheeler, F. C., Loyd, J. E., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201502-0407oc · Cited by 70
Fischer, M. A., Davies, M. L., Reider, I. E., Heipertz, E. L., Epler, M., Sei, J. J., Ingersoll, M. A., van Rooijen, N., Randolph, G. J., & Norbury, C. C. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002374 · Cited by 63
Burton, V. J., Holmes, A. M., Ciuclan, L. I., Robinson, A., Roger, J., Járai, G., Pearce, A. C., & Budd, D. C. (2011) · Blood · doi:10.1182/blood-2011-05-347393 · Cited by 50
Endothelin-1 and interleukin-8 in high altitude pulmonary oedema
Droma, Y., Hayano, T., Takabayashi, Y., Koizumi, T., Kubo, K., Kobayashi, T., & Sekiguchi, M. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09091947 · Cited by 50
Circulating Myeloid-Derived Suppressor Cells Are Increased and Activated in Pulmonary Hypertension
Yeager, M. E., Nguyen, C. M., Belchenko, D. D., Colvin, K. L., Takatsuki, S., Ivy, D. D., & Stenmark, K. R. (2011) · CHEST Journal · doi:10.1378/chest.11-0205 · Cited by 48
Lee, A. H., Dhaliwal, R., Kantores, C., Ivanovska, J., Gosal, K., McNamara, P. J., Letarte, M., & Jankov, R. P. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0131oc · Cited by 43
BMP Pathway Regulation of and by Macrophages
Talati, M. H., West, J. D., Zaynagetdinov, R., Hong, C. C., Han, W., Blackwell, T., Robinson, L., Blackwell, T. S., & Lane, K. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094119 · Cited by 32
Bryant, A. J., Robinson, L. J., Moore, C. S., Blackwell, T. R., Gladson, S., Penner, N. L., Burman, A., McClellan, L. J., Polosukhin, V. V., Tanjore, H., et al. (2015) · Pulmonary Circulation · doi:10.1086/683811 · Cited by 31
Self-citationCXCR2 deficient mice display macrophage-dependent exaggerated acute inflammatory responses
Dyer, D. P., Pallas, K. J., Medina‐Ruiz, L., Schuette, F., Wilson, G. J., & Graham, G. J. (2017) · Scientific Reports · doi:10.1038/srep42681 · Cited by 31
Neonatal Hyperoxia Increases Sensitivity of Adult Mice to Bleomycin-Induced Lung Fibrosis
Yee, M., Buczynski, B. W., Lawrence, B. P., & O’Reilly, M. A. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0238oc · Cited by 26
Nagai, H., Kuwahira, I., Schwenke, D. O., Tsuchimochi, H., Nara, A., Ogura, S., Sonobe, T., Inagaki, T., Fujii, Y., Yamaguchi, R., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131923 · Cited by 24
Identification of Key Cost Generating Events for Idiopathic Pulmonary Fibrosis: A Systematic Review
Vaidya, S., Hibbert, C. L., Kinter, E. T., & Boes, S. (2016) · Lung · doi:10.1007/s00408-016-9960-6 · Cited by 23
Martire‐Greco, D., Rodriguez‐Rodrigues, N., Castillo, L. A., Vecchione, M. B., de Campos‐Nebel, M., Córdoba-Moreno, M. O., Meiss, R. P., Vermeulen, M. E., Landoni, V. I., & Fernández, G. C. (2016) · Shock · doi:10.1097/shk.0000000000000812 · Cited by 19
Giordano, S. S., Zhao, X., Xing, D., Hage, F. G., Oparil, S., Cooke, J. P., Lee, J., Nakayama, K. H., Huang, N. F., & Chen, Y.-F. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00587.2015 · Cited by 13
Cited by
Macrophages: versatile players in renal inflammation and fibrosis
Tang, P. M.-K., Nikolic-Paterson, D. J., & Lan, H.-Y. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0110-2 · Cited by 1,033
The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis
Desai, O., Winkler, J., Minasyan, M., & Herzog, E. L. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00043 · Cited by 314
Self-citationPFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension
Cao, Y., Zhang, X., Wang, L., Yang, Q., Ma, Q., Xu, J., Wang, J., Kovacs, L., Ayon, R. J., Liu, Z., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821401116 · Cited by 213
The vascular perspective on acute and chronic lung disease
Borek, I., Birnhuber, A., Voelkel, N. F., Marsh, L. M., & Kwapiszewska, G. (2023) · Journal of Clinical Investigation · doi:10.1172/jci170502 · Cited by 103
Regulatory Immune Cells in Idiopathic Pulmonary Fibrosis: Friends or Foes?
van Geffen, C., Deißler, A., Quante, M., Renz, H. E., Hartl, D., & Kolahian, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663203 · Cited by 88
Metadata
- Authors
- Bryant, A. J., Shenoy, V., Fu, C., Marek, G., Lorentsen, K. J., Herzog, E. L., Brantly, M. L., Avram, D., & Scott, E. W.
- Affiliations
- University of Florida (US)
- California Health Sciences University (US)
- Yale University (US)
- Corresponding author
- Bryant, Andrew J.
- ORCID
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-02-01
- Volume
- 58
- Issue
- 2
- Pages
- 170-180
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- PMC
- PMC5805999
- OpenAlex
- W2751016427
- Cited by
- 47
- References
- 70
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 2 · 2023: 5 · 2022: 8 · 2021: 7 · 2020: 1 · 2019: 6 · 2018: 8
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (KL2TR001429)
- National Institute on Aging (P30AG028740)
- National Heart, Lung, and Blood Institute (R01HL109233)
- National Institute of Allergy and Infectious Diseases (R01AI067846, R21AI131205, T32AI007110)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK105916)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- myeloid-derived suppressor cells, pulmonary hypertension, idiopathic pulmonary fibrosis, CXCR2, granulocytic MDSCs, clodronate liposomes, bleomycin-induced lung fibrosis, bone marrow-derived cells, chemokine receptor inhibition, pathogenesis
- MeSH terms
- Myeloid-Derived Suppressor Cells, Animals, Arginase, Bleomycin, Cell Movement, Clodronic Acid, Female, Hypertension, Pulmonary, Male, Mice, Inbred C57BL, Phenylurea Compounds, Interleukin-8, Myeloid Cells, Receptors, Interleukin-8B, Mice, Nitric Oxide Synthase Type II, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.